MRNA
Moderna
October 22, 2026 · intraday
- Rarity
- 1.70
- Peak move
- −19.88%
- Float cap
- $88.6B
Still running — rarity and peak move can only rise from here.
Moderna is a biotechnology company that develops messenger RNA (mRNA) medicines, selling its COVID-19 vaccines Spikevax and mNEXSPIKE, plus the RSV vaccine mRESVIA, to wholesalers, distributors, retailers, governments and international organizations. It also runs late-stage programs in seasonal flu, combination flu-COVID and norovirus vaccines, personalized cancer therapies with Merck, and rare disease treatments. Founded in 2010 and based in Cambridge, Massachusetts, it sells mainly in the United States, Europe and other global markets.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.